BIOLOGY OF TRABECULAR MESHWORK IN HEALTH AND DISEASE
小梁网在健康和疾病中的生物学
基本信息
- 批准号:2159498
- 负责人:
- 金额:$ 22.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-12-01 至 2000-07-31
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction cell adhesion collagen enzyme linked immunosorbent assay extracellular matrix proteins fibronectins flow cytometry glaucoma glucocorticoids growth factor human tissue immunocytochemistry immunoelectron microscopy immunofluorescence technique immunoprecipitation integrins intraocular pressure laminin messenger RNA northern blottings organ culture protein structure function tissue /cell culture trabecular meshwork western blottings
项目摘要
The trabecular meshwork (TM) is believed to be a major site for the
regulation of the aqueous outflow. Residing in this tissue are TM cells
that are essential for the maintenance of normal outflow. Aberrations of
cell integrity may be a key step toward obstruction of the aqueous
outflow, intraocular pressure elevations, and glaucomatous conditions.
Along with the cells, extracellular matrix (ECM) materials such as
fibronectin, laminin, and collagens are also thought to be important for
normal functioning of the TM. We propose, in this application, to examine
a family of receptors for ECM proteins, the integrins, and the cell-matrix
interactions in the human TM. The integrins are known to interact with
cytoskeletal proteins, mediate cell attachment, and influence a variety of
cellular activities. They are also crucial in the determination of growth,
morphology, metabolism, and differentiation of cells. In the TM system,
cells line the trabecular beams that are made up of connective tissues.
The TM cells in vivo are continually subjected to flows of the aqueous
humor and changes in the intraocular pressure. The lining integrity
against stress is critically dependent on the adhesion of TM cells to the
matrices through integrin receptors. Disruption in the adhesion of TM
cells to the ECM would conceivably lead to cell loss, denudation of the
beams, and pathologic consequences. Characterization of the integrins and
elucidation of the cell-matrix interactions in the TM are therefore of
fundamental significance.
We have initiated investigations on integrins and have found that the
integrin repertoire in cultured TM cells is similar to that in tissues. We
will further our efforts to evaluate the roles of integrins in adhesion of
cultured TM cells to the ECM and to determine the integrin-mediated
signaling pathways by immunoprecipitation, immunofluorescence staining and
other methods. Activators and inhibitors will be used to define further
the potential signaling mechanisms involved. We propose to dissect
systematically the information transduced by cell-ECM interactions using
the in vitro human TM cultures coupled with defined matrices. The effects
of individual ECM substrata on the integrin distribution and biologic
characteristics of TM cells will be assessed by cell biology and molecular
biology techniques. To probe the functional roles of integrins, human TM
cells will be transfected to result in either enhanced or suppressed
expression of specific integrins. The effects of gene alterations will be
analyzed. In addition, the integrin distribution and expression in
conditions that are known to induce ECM changes in TM cells, such as after
phagocytic challenges and after glucocorticoid treatments, will be
examined. Modulation in the integrins will be correlated with the ECM
changes. The effects of growth factors on the production and expression of
fibronectin, laminin, collagen, and integrins by TM cells in both cell
culture and organ culture systems will also be investigated. Protocols of
immunohistochemical staining, and dot blot, Western blot and Northern blot
analyses will be followed.
Our goal is to increase the understanding of the biologic characteristics
of healthy as well as experimentally-altered TM cells, particularly with
regard to the dynamics and control mechanisms involved in the cell-matrix
interactions in the TM. This information will assist in uncovering the
pathogenic processes of glaucomas.
据信小梁网(TM)是
水流出的调节。居住在该组织中的是TM细胞
这对于维持正常流出至关重要。畸变
细胞完整性可能是障碍物阻塞的关键步骤
流出,眼内压升高和青光眼条件。
与细胞一起,细胞外基质(ECM)材料(例如
纤连蛋白,层粘连蛋白和胶原蛋白也被认为对
TM的正常功能。我们建议在此应用中检查
ECM蛋白质,整合素和细胞矩阵的受体家族
人类TM的相互作用。已知整联蛋白与
细胞骨架蛋白,介导细胞附着并影响多种
细胞活动。它们对于确定增长至关重要,
细胞的形态,代谢和分化。在TM系统中,
细胞为由结缔组织组成的小梁梁排列。
体内的TM细胞不断受到水的流量
眼内压的幽默和变化。衬里完整性
反对压力取决于TM细胞对
通过整联蛋白受体进行矩阵。 TM粘附的破坏
到ECM的细胞可能会导致细胞丢失,剥夺
梁和病理后果。整合素和的表征
因此,阐明TM中的细胞基质相互作用是
基本意义。
我们已经开始对整合素的调查,发现
培养的TM细胞中整合素库与组织中的曲目相似。我们
将进一步努力评估整合素在粘附中的作用
培养的TM细胞到ECM并确定整联蛋白介导的
免疫沉淀,免疫荧光染色和信号通路
其他方法。激活剂和抑制剂将用于进一步定义
潜在的信号传导机制。我们建议剖析
系统地,使用细胞ECM相互作用转导的信息
体外人类TM培养物与定义的矩阵结合。效果
在整联蛋白分布和生物学上的单个ECM基质
TM细胞的特征将通过细胞生物学和分子评估
生物学技术。为了探测整联蛋白的功能作用,人类TM
细胞将被转染以导致增强或抑制
特定整合素的表达。基因改变的影响将是
分析。另外,整联蛋白的分布和表达
已知会在TM细胞中诱导ECM变化的疾病,例如
吞噬挑战和糖皮质激素治疗后,将是
检查。整联蛋白中的调节将与ECM相关
更改。生长因子对生产和表达的影响
两个细胞中TM细胞的纤连蛋白,层粘连蛋白,胶原蛋白和整联蛋白
文化和器官培养系统也将进行研究。协议的
免疫组织化学染色,以及点印迹,蛋白质印迹和北印迹
将遵循分析。
我们的目标是提高对生物学特征的理解
健康和实验改变的TM细胞,特别是
关于细胞矩阵涉及的动力和控制机制
TM中的相互作用。此信息将有助于发现
青光眼的致病过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BEATRICE Y.J.T. YUE其他文献
BEATRICE Y.J.T. YUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BEATRICE Y.J.T. YUE', 18)}}的其他基金
Cellular Processing of Optineurin, the Product of a Glaucoma Gene
青光眼基因产物 Optineurin 的细胞加工
- 批准号:
7577989 - 财政年份:2009
- 资助金额:
$ 22.03万 - 项目类别:
Cellular Processing of Optineurin, the Product of a Glaucoma Gene
青光眼基因产物 Optineurin 的细胞加工
- 批准号:
8142361 - 财政年份:2009
- 资助金额:
$ 22.03万 - 项目类别:
Cellular Processing of Optineurin, the Product of a Glaucoma Gene
青光眼基因产物 Optineurin 的细胞加工
- 批准号:
7759139 - 财政年份:2009
- 资助金额:
$ 22.03万 - 项目类别:
Cellular Processing of Optineurin, the Product of a Glaucoma Gene
青光眼基因产物 Optineurin 的细胞加工
- 批准号:
8018096 - 财政年份:2009
- 资助金额:
$ 22.03万 - 项目类别:
Cellular Processing of Optineurin, the Product of a Glaucoma Gene
青光眼基因产物 Optineurin 的细胞加工
- 批准号:
8215667 - 财政年份:2009
- 资助金额:
$ 22.03万 - 项目类别:
相似国自然基金
“类酶”仿生体系下胶原支架调控细胞粘附性的功能强化及性能优化机制
- 批准号:32101081
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
“类酶”仿生体系下胶原支架调控细胞粘附性的功能强化及性能优化机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
粘附分子对硬皮病纤维母细胞胶原合成的调控及机制
- 批准号:39670673
- 批准年份:1996
- 资助金额:9.0 万元
- 项目类别:面上项目
粘附分子对创面愈合时成纤维细胞胶原合成的调控及机理
- 批准号:39670743
- 批准年份:1996
- 资助金额:11.0 万元
- 项目类别:面上项目
肝实质细胞癌细胞在胶原蛋白Ⅳ裱衬表面的粘附力学研究
- 批准号:39500037
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Modulation of Protein S-nitrosylation Signaling as a Potential Therapeutic Breakthrough in Rheumatoid Arthritis
调节蛋白质 S-亚硝基化信号传导是类风湿关节炎的潜在治疗突破
- 批准号:
10817318 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
The cadherin Desmoglein-2 controls cell spreading and extracellular matrix gene expression.
钙粘蛋白 Desmoglein-2 控制细胞扩散和细胞外基质基因表达。
- 批准号:
10653447 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Mechanisms guiding the fibrillar assembly of SNED1 in the extracellular matrix
指导细胞外基质中 SNED1 纤维组装的机制
- 批准号:
10733534 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Development of a patient-derived tumoroid culture system to explore novel medical treatments for refractory prolactinomas
开发患者源性肿瘤培养系统,探索难治性泌乳素瘤的新疗法
- 批准号:
10643450 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Nanostructured Hydrogel Surfaces for Artificial Extracellular Matrix
用于人工细胞外基质的纳米结构水凝胶表面
- 批准号:
10373590 - 财政年份:2022
- 资助金额:
$ 22.03万 - 项目类别: